TriSalus Life Sciences secures FDA 510(k) clearance for device
TriSalus Life Sciences said it received FDA 510(k) clearance for a new pressure-enabled drug delivery device; TLSI shares surged 26% to $6.21 after Tuesday’s close.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.